Trial intelligence / Profile preview

Hyaluronic Acid + Rehabilitation in Adhesive Capsulitis

NCT07570095Completed

Sponsor
Tri-Service General Hospital
Start
Feb 2025
Primary completion
Mar 2025
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of hyaluronic acid in adhesive capsulitis (AC) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Shoulder Pain and Disability Index Total Score at 12 weeks. Started Feb 2025; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on NCT07570095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07570095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call